The impact of the frequency of short contact dithranol treatment

European Journal of Dermatology

Volumn 11, Issue 3, 2001, Pages 214-218

  Prins, Mandy ^a   Swinkels, O Quintus J ^a   Van de Kerkhof, Peter C M ^a   Van der Valk, Pieter G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Day care; Psoriasis; Short contact therapy

Indexed keywords

ASCORBIC ACID; CETOSTEARYLIC ALCOHOL; DITHRANOL; OLEIC ACID; SALICYLIC ACID; SORBIC ACID; SORBITOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HUMAN; MALE; PSORIASIS; SHORT COURSE THERAPY;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, TOPICAL; ADULT; AGED; ANTHRALIN; ANTI-INFLAMMATORY AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 0034996373     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. 1. Murdoch D, Clissold SP. Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris. Drugs 1992; 43: 415-29.
2. 2. van Dijk E, Bakkers EJ, Go MJ, et al. Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 per cent cream. Cutis 1983; 32: 284-5, 7.
3. 3. Svartholm H, Larsson L, Frederiksen B. Intermittent topical treatment of psoriasis with clobetasol propionate ("Dermovate"). Curr Med Res Opin 1982; 8: 154-7.
4. 4. Runne U, Kunze J. ["Minute therapy" of psoriasis with dithranol and its modifications. A critical evaluation based on 315 patients] Die "Minuten-therapie" der Psoriasis mit Dithranol und ihre Modifikationen. Eine kritische Wertung anhand von 315 Patienten. Hautarzt 1985; 36: 40-6.
5. 5. Statham BN, Rowell NR. Short contact dithranol therapy-twice daily and high concentration regimes (letter). Br J Dermatol 1985; 113: 245-6.
6. 6. Fredriksson T, Pettersson U. Severe Psoriasis - Oral Therapy with a New Retinoid. Dermatologica 1978; 157: 238-44.
7. 7. Marks R, Barton SP, Shuttleworth D, et al. Assessment of disease progress in psoriasis. Arch Dermatol 1989; 125: 235-40.
8. 8. Prins M, Swinkels OQJ, Bouwhuis S et al. Dithranol in a cream preparation: disperse or dissolve? Skin Pharmacol Appl Skin Physiol 2000; 13: 273-9.
9. 9. Ros JJW, Van der Meer YG. Preparation, analysis and stability of oil-in-water creams containing dithranol. Eur J Hosp Pharm 1991; 1: 77-84.
10. 10. de Mare S, Calis N, den Hartog G, et al. Outpatient treatment with short-contact dithranol. The impact or frequent concentration adjustments. Acta Derm Venereol 1989: 69: 449-51.
11. 11. Runne U, Kunze J. Short-duration ("minutes") therapy with dithranol for psoriasis: a new out-patient regimen. Br J Dermatol 1982, 106: 135-9.
12. 12. Schaefer H, Farber EM, Goldberg L, et al. Limited application period for dithranol in psoriasis. Preliminary report on penetration and clinical efficacy. Br J Dermatol 1980; 102: 571-3.
13. 13. Schwarz T, Gschnait F. Anthralin minute entire skin treatment. A new outpatient therapy for psoriasis. Arch Dermatol 1985; 121: 1512-5.
14. 14. Statham BN, Ryatt KS, Rowell NR. Short-contact dithranol therapy-a comparison with the Ingram regime. Br J Dermatol 1984; 110: 703-8.
15. 15. Harris DR. Old wine in new bottles: the revival of anthralin. Cutis 1998; 62: 201-3.
16. 16. van der Vleuten CJM, Gerritsen MJP, de Jong EMGJ, et al. A novel Dithranol formulation (Micanol): the effects of monotherapy and UVB combination therapy on epidermal differentiation, proliferation and cutaneous inflammation in psoriasis vulgaris. Acta Derm Venereol 1996; 76: 387-91.
17. 17. Carrozza P, Hausermann P, Nestle FO, et al. Clinical efficacy of narrow-band UVB (311 nm) combined with dithranol in psoriasis. An open pilot study. Dermatology 2000; 200: 35-9.
18. 18. Lebwohl M. Topical application of calcipotriene and corticosteroids: Combination regimens. J Am Acad Dermatol 1997; 37: S55-8.